A Randomized Controlled Trial of Glycyrrhizin Plus Tenofovir vs. Tenofovir in Chronic Hepatitis B with Severe Acute Exacerbation

OBJECTIVES: Severe acute exacerbation (SAE) of chronic hepatitis B (CHB) may progress to liver failure with high potential mortality despite the prompt treatment with nucleos(t)ide analogs. This study aimed to evaluate the efficacy and safety of glycyrrhizin in the treatment of CHB with SAE. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Hung, Chao-Hung, Kee, Kwong-Ming, Chen, Chih-Hung, Tseng, Po-lin, Tsai, Ming-Chao, Chen, Chien-Hung, Wang, Jing-Houng, Chang, Kuo-Chin, Kuo, Yuan-Hung, Yen, Yi-Hao, Hu, Tsung-Hui, Lu, Sheng-Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518952/
https://www.ncbi.nlm.nih.gov/pubmed/28662023
http://dx.doi.org/10.1038/ctg.2017.29

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518952/
https://www.ncbi.nlm.nih.gov/pubmed/28662023
http://dx.doi.org/10.1038/ctg.2017.29

Ejemplares similares